Long-term outcome and prognostic factors of single-dose Radioiodine Therapy in patients with Graves' disease
ConclusionsIn Taiwan, RAI therapy for GD patients reached an overall success rate of 70.9%, with a median dose of 7 mCi. This study identified patients with grade 3 goiter need a more aggressive RAI regimen.
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
More News: Chia | General Medicine | Hyperthyroidism | Hypothyroidism | Radioiodine Therapy | Study | Taiwan Health